JoVE Logo

Zaloguj się

A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice

11.4K Views

07:38 min

April 13th, 2018

DOI :

10.3791/56443-v

April 13th, 2018


Przeglądaj więcej filmów

Micro CT

Rozdziały w tym wideo

0:04

Title

0:56

Intratracheal Administration of Bleomycin

1:46

Probe Injection for Fluorescence Molecular Tomography

2:25

Fluorescence Molecular Tomography Imaging

3:45

In Vivo Imaging by Micro-CT

5:45

Results: Time-course and Quantification of Bleomycin-induced Lung Fibrosis

7:09

Conclusion

Powiązane Filmy

article

08:57

High Resolution 3D Imaging of Ex-Vivo Biological Samples by Micro CT

18.6K Views

article

08:04

Monitoring Tumor Metastases and Osteolytic Lesions with Bioluminescence and Micro CT Imaging

24.5K Views

article

05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

6.7K Views

article

12:24

Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers

12.3K Views

article

05:15

Noninvasive Intratracheal Intubation to Study the Pathology and Physiology of Mouse Lung

24.6K Views

article

13:45

Hybrid µCT-FMT imaging and image analysis

13.1K Views

article

11:31

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

10.6K Views

article

06:52

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin

17.1K Views

article

09:02

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

13.5K Views

article

07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

6.7K Views

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone